By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

Contact Information

Website: www.acimmune.com
Email: ir@acimmune.com
Main Phone: +41 216939121
Address: EPFL Innovation Park
Address 2: Building B
City / Town: Lausanne
Country: CH
Postal Code: 1015

Issuer Information

Exchange: NSD
CEO: Andrea Pfeifer
Employees: 149

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A